Dr. Elias A. Zerhouni has been the chairman and co-founder of ModeX therapeutics Inc., a start-up biotechnology company focused on multi specific-immune therapies for cancer and viral diseases, since November 2020. A physician scientist in Imaging and Biomedical Engineering, he served as President of global R&D and executive Vice President of Sanofi form 2010-2018, as Senior Fellow for global health research at the Bill and Melinda Gates foundation 2009-2010 and Presidential US envoy for science and technology 2009-2010. He was director of the US national Institutes of Health 2002-2008, Executive Vice Dean and Dean for research at the Johns Hopkins School of medicine 1996-2002, Professor of Radiology and Biomedical Engineering and chair of the department of Radiological sciences. Dr Zerhouni was elected to the National Academy of Medicine and to the National Academy of Engineering. He serves on the Board of the Lasker Foundation, the Foundation for NIH and the board of Research!America. He received the 2017 Scripps Executive of the year Award for the pharmaceutical industry and the French Legion of Honor in 2008. He has been a director of the publicly traded Danaher Corporation since 2009 to the present.